TERMINATION AGREEMENTTermination Agreement • July 7th, 2009 • Oxigene Inc • Biological products, (no disgnostic substances) • New York
This TERMINATION AGREEMENT (this “Agreement”), is entered into as of July 2, 2009, by and among OXiGENE, INC., a Delaware corporation (the “Company”), SYMPHONY ViDA HOLDINGS LLC, a Delaware limited liability company (“Holdings”), SYMPHONY ViDA INVESTORS LLC, a Delaware limited liability company (“Investors”), and SYMPHONY ViDA, INC., a Delaware corporation (the “Symphony Collaboration”).
AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT between OXiGENE, INC. and SYMPHONY ViDA HOLDINGS LLC Dated as of July 2, 2009Registration Rights Agreement • July 7th, 2009 • Oxigene Inc • Biological products, (no disgnostic substances) • New York
AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of July 2, 2009, by and between OXiGENE, INC., a Delaware corporation (the “Company”), and SYMPHONY ViDA HOLDINGS LLC, a Delaware limited liability company (together with its permitted successors, assigns and transferees, “Holdings”).
AMENDED AND RESTATED PURCHASE OPTION AGREEMENT by and among OXiGENE, INC. SYMPHONY ViDA HOLDINGS LLC and SYMPHONY ViDA, INC.Purchase Option Agreement • July 7th, 2009 • Oxigene Inc • Biological products, (no disgnostic substances) • Delaware
This AMENDED AND RESTATED PURCHASE OPTION AGREEMENT (this “Agreement”) is entered into as of July 2, 2009 (the “Closing Date”), by and among OXiGENE, INC., a Delaware corporation (the “Company”), SYMPHONY ViDA HOLDINGS LLC, a Delaware limited liability company (“Holdings”), and SYMPHONY ViDA, INC., a Delaware corporation (the “Symphony Collaboration”). Capitalized terms used herein and not defined herein shall have the meanings assigned to such terms in Annex A attached hereto.
